United Therapeutics
E1559021
UNEXPLORED
United Therapeutics is a biotechnology company focused on developing and commercializing therapies for pulmonary arterial hypertension and other serious cardiopulmonary conditions.
All labels observed (1)
| Label | Occurrences |
|---|---|
| United Therapeutics canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T22880684 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: United Therapeutics Context triple: [Tommy Thompson, boardMemberOf, United Therapeutics]
-
A.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
B.
Alexion Pharmaceuticals
Alexion Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for rare and severe diseases, particularly in the field of complement biology.
-
C.
Novartis Gene Therapies
Novartis Gene Therapies is a biotechnology company within Novartis focused on developing and commercializing gene therapy treatments for rare and life-threatening genetic diseases.
-
D.
Guardant Health
Guardant Health is a precision oncology company specializing in blood-based liquid biopsy tests to detect, monitor, and guide treatment of cancer.
-
E.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: United Therapeutics Target entity description: United Therapeutics is a biotechnology company focused on developing and commercializing therapies for pulmonary arterial hypertension and other serious cardiopulmonary conditions.
-
A.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
B.
Alexion Pharmaceuticals
Alexion Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for rare and severe diseases, particularly in the field of complement biology.
-
C.
Novartis Gene Therapies
Novartis Gene Therapies is a biotechnology company within Novartis focused on developing and commercializing gene therapy treatments for rare and life-threatening genetic diseases.
-
D.
Guardant Health
Guardant Health is a precision oncology company specializing in blood-based liquid biopsy tests to detect, monitor, and guide treatment of cancer.
-
E.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject linked to:
Tommy George Thompson